Monographie - Amoxicillin sodium / clavulanic acid

Последно актуализиране :
19/11/2024

Amoxicillin sodium / clavulanic acid

Химична структура

Търговско наименование

Търговските имена са примерни и съставът на помощните вещества може да бъде различен в зависимост от държавата и лабораториите

Aktil	Унгария
Amoclan	Саудитска Арабия
Amoklavin	Турция
Amoksiklav	Полша
Amoxclav	Саудитска Арабия
Amplamox	Бразилия
Augmentin	Австрия, Белгия, Великобритания, Гърция, Еквадор, Испания, Италия, Обединени арабски емирства, Полша, Саудитска Арабия, Турция, Франция, Холандия, Чили, Швейцария
Betamox	Португалия
Clavamox	Австрия
Clavicin	Венецуела, Малайзия
Clavulin	Бразилия
Co-amoxi	Швейцария
Co-Amoxicillin	Швейцария
Curam	нова Зеландия, Саудитска Арабия
Darzitil	Аржентина
Dibional	Аржентина
Julmentin	Обединени арабски емирства
Novamox	Бразилия
Sulbamox	Чили
Tarometin	Полша
Trifamox	Аржентина, Еквадор, Колумбия, Мексико

Библиография : Amoxicillin sodium / clavulanic acid

	Вид	Публикация
186	Списание	Swart EL, Mooren RAG, Van Loenen AC. Compatibility of midazolam hydrochloride and lorazepam with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1995 ; 52: 2020-2022.
889	Списание	Janknegt R, Stratermans T, Cilissen J, Lohman JJHM, Hooymans PM. Ofloxacin intravenous. Compatibility with other antibacterial agents. Pharm Weekbl [Sci] 1991 ; 13: 207-209.
1318	Списание	Ashwin J, Lynn B, Taskis CB. Stability and administration of intravenous Augmentin. Pharm J 1987 ; 238: 116-118.
1357	Списание	Janknegt R, Schrouff GGM, Hooymans PM, Hermens WJHH, Lohman JJHM. Quinolones and penicillins incompatibility. Ann Pharmacotherapy 1989 ; 23: 91-92.
1746	Списание	Kambia N, Merite N, Dine T, Dupin-Spriet T, Gressier B, Luyckx M, Watinne C, Brunet C. Stability studies of amoxicillin/clavulanic acid combinaison in polyolefin infusion bags. EJHP 2010 ; 16, 30-37.
2139	Списание	Serrurier C, Chenot ED, Vigneron J, May I, Demor? B. Assessment of injectable drug’s administration in two intensive care units and determination of potential physico-chemical incompatibilities. EJHP Science 2006 ; 12,5: 96-99.
2231	Списание	de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S. Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection. J Antimicrob Chemother 2008 ; 61, 2: 382-388.
3520	Лаборатория	Cidomycin - Summary of product Chracteristics. Sanofi 2011
3529	Лаборатория	Ciprofloxacin – Summary of Product Characteristics Hospira 2013
3545	Лаборатория	Amoxicilline / acide clavulanique - Résumé des caractéristiques du produit Mylan SAS 2009
3549	Лаборатория	Amikacine B Braun - Résumé des caractéristiques du produit. B Braun 2012
3643	Лаборатория	Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics Sanofi 2015
3674	Лаборатория	Erythromycin lactobionate - Summary of Product Characteristics PanPharma 2016
3791	Плакат	Sadou Yaye H, Burtet E, Hamel C, Aljhni R, Gard C, Tilleul P. Étude de la compatibilité physico-chimique du phloroglucinol injectable durant les mélanges au sein des tubulures en Y. Apifh Congress, Paris November 2014 2014
3824	Списание	Boudi S, Roy H, Forest JM, Leclair G. Compatibilité physique de l'association amoxicilline-acide clavulanique en injection avec plusieurs autres médicaments lors d'une administration en Y. Pharmactuel 2023 2023;56,3:91-98
3948	Списание	Bouchoud L, Fonzo-Christe C, Klingm?ller M, Bonnabry P . Compatibility of Intravenous Medications With Parenteral Nutrition - In Vitro Evaluation. JPEN 2012 ;30. 416?424.
4470	Списание	Claeysoone K, Basma V, Hens R, Van Bambeke F, de Jongh R, Tulkens P. Continuous versus intermittent infusion of temocillin in intensive care unit patient. Critical care 2005 ; 9(Suppl 1) P37
4524	Плакат	Stucki C, Sautter A-M, Bonnabry P. Physical compatibility of the propofol emulsion with 33 drugs used in anaesthesiology. ESCP Symposium, Geneva, Switzerland 2009
4654	Плакат	Sicard G, Donnette M, Martin N, Gensollen S, Pourroy B, Fanciullino R. Compatibilité visuelle du Vyxeos® lors d'administration en Y avec une sélection de médicaments injectables. Communication personnelle 2021

Mentions Légales